Evidence map›Paper›PMID 37692477›Full record

ReviewGenes & diseases2024

Cancer organoids: A platform in basic and translational research.

Xin Ma, Qin Wang, Guozheng Li, Hui Li, Shouping Xu, Da Pang

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Genes & diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Organoid technology in cancer research.Molecular biomedicine · 2026
    Review
  4. Review
  5. Review
  6. Tumor organoids modeling reveals timed responses and interplay of radiotherapy and chemotherapy in pancreatic cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xin MaDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
Qin WangSino-Russian Medical Research Center, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
Guozheng LiDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
Hui LiDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
Shouping XuDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
Da PangDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An accumulation of previous work has established organoids as good preclinical models of human tumors, facilitating translation from basic research to clinical practice. They are changing the paradigm of preclinical cancer research because they can recapitulate the heterogeneity and pathophysiology of human cancers and more closely approximate the complex tissue environment and structure found in clinical tumors than

Indexed as

Drug assaysImmunotherapyMechanism researchOrganoidsPrecision medicine

Identifiers

PMID37692477
PMCPMC10491878
OpenAlexW4365148139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.